How Biotech Startups Can Have a Stronger Position When Scaling Up

| January 21, 2020

article image
Scaling up the manufacturing process can be a daunting task for any biotech startup. Evelina Vågesjö, CEO of Swedish gene therapy biotech Ilya Pharma, and Jesper Hedberg, Director of the Testa Center facility, explained how testing at innovation facilities such as incubators and accelerators can help avoid big pitfalls in the scaling process later on.  At some point, a biotech startup will need to produce its product at a big scale. For example, regulators such as the FDA and EMA require a Good Manufacturing Practice standard for drugs to be approved. However, the process of scaling up production in the biotech world isn’t easy.

Spotlight

DNA SOLUTIONS

DNA Solutions have been assisting individuals around the globe with DNA Paternity & relationship analysis & were the first pioneering company offering DNA home kits to test for paternity and introduced these back in the 90’s. Many of our technical staff and management are ex-police and ex-military DNA testing forensic scientists, further enhancing the quality and range of our DNA tests. Processing occurs in our own DNA laboratory, our lab is capable of DNA ancestry testing, paternity testing, relationship tests, DNA banking and preservation, where we additionally carry out extensive research and development. We have offices and laboratories worldwide & serve thousands of individuals and organizations globally

OTHER ARTICLES
MEDICAL

Better Purification and Recovery in Bioprocessing

Article | August 2, 2021

In the downstream portion of any bioprocess, one must pick through the dross before one can seize the gold the biotherapeutic that the bioprocess was always meant to generate. Unfortunately, the dross is both voluminous and various. And the biotherapeutic gold, unlike real gold, is corruptible. That is, it can suffer structural damage and activity loss. When discarding the dross and collecting the gold, bioprocessors must be efficient and gentle. They must, to the extent possible, eliminate contaminants and organic debris while ensuring that biotherapeutics avoid aggregation-inducing stresses and retain their integrity during purification and recovery. Anything less compromises purity and reduces yield. To purify and recover biotherapeutics efficiently and gently, bioprocessors must avail themselves of the most appropriate tools and techniques. Here, we talk with several experts about which tools and techniques can help bioprocessors overcome persistent challenges. Some of these experts also touch on new approaches that can help bioprocessors address emerging challenges.

Read More
DIAGNOSTICS

Making Predictions by Digitizing Bioprocessing

Article | April 20, 2021

With advances in data analytics and machine learning, the move from descriptive and diagnostic analytics to predictive and prescriptive analytics and controls—allowing us to better forecast and understand what will happen and thus optimize process outcomes—is not only feasible but inevitable, according to Bonnie Shum, principal engineer, pharma technical innovation, technology & manufacturing sciences and technology at Genentech. “Well-trained artificial intelligence systems can help drive better decision making and how data is analyzed from drug discovery to process development and to manufacturing processes,” she says. Those advances, though, only really matter when they improve the lives of patients. That’s exactly what Shum expects. “The convergence of digital transformation and operational/processing changes will be critical for the facilities of the future and meeting the needs of our patients,” she continues. “Digital solutions may one day provide fully automated bioprocessing, eliminating manual intervention and enabling us to anticipate potential process deviations to prevent process failures, leading to real-time release and thus faster access for patients.” To turn Bioprocessing 4.0 into a production line for precision healthcare, real-time release and quickly manufacturing personalized medicines will be critical. Adding digitization and advanced analytics wherever possible will drive those improvements. In fact, many of these improvements, especially moving from descriptive to predictive bioprocessing, depend on more digitization.

Read More

Spotlight

DNA SOLUTIONS

DNA Solutions have been assisting individuals around the globe with DNA Paternity & relationship analysis & were the first pioneering company offering DNA home kits to test for paternity and introduced these back in the 90’s. Many of our technical staff and management are ex-police and ex-military DNA testing forensic scientists, further enhancing the quality and range of our DNA tests. Processing occurs in our own DNA laboratory, our lab is capable of DNA ancestry testing, paternity testing, relationship tests, DNA banking and preservation, where we additionally carry out extensive research and development. We have offices and laboratories worldwide & serve thousands of individuals and organizations globally

Events